TY - JOUR
T1 - Picosecond lasers for tattoo removal
T2 - a systematic review
AU - Reiter, Ofer
AU - Atzmony, Lihi
AU - Akerman, Lehavit
AU - Levi, Assi
AU - Kershenovich, Ruben
AU - Lapidoth, Moshe
AU - Mimouni, Daniel
N1 - Publisher Copyright:
© 2016, Springer-Verlag London.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Given that the pigment particles in tattoos have a relaxation time of <10 ns, picosecond lasers would be expected to be more effective than nanosecond lasers in tattoo removal. To systematically review the evidence regarding the effectiveness and safety of picosecond lasers for tattoo removal, Pubmed, Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov, and reference lists were searched for relevant trials. The primary outcome was >70 % clearance of tattoo pigment. Secondary outcomes were 90–100 % clearance of tattoo pigment, number of laser sessions required, and adverse effects. Eight trials were included, six with human participants (160 participants) and 2 with animal models. Seven of the eight trials explored the usage of either 755, 758, 795, 1064, or 1064/532-nm picosecond lasers for black and blue ink tattoos. In the human trials, 69–100 % of tattoos showed over 70 % clearance of pigment after 1–10 laser treatments. Reported side effects included pain, hyperpigmentation and hypopigmentation, blister formation and transient erythema, edema, and pinpoint bleeding. Included articles varied in type of laser investigated, mostly non-comparative studies and with a medium to high risk of bias. There is sparse evidence that picosecond lasers are more effective than their nanosecond counterparts for mainly black and blue ink tattoo removal, with minor side effects.
AB - Given that the pigment particles in tattoos have a relaxation time of <10 ns, picosecond lasers would be expected to be more effective than nanosecond lasers in tattoo removal. To systematically review the evidence regarding the effectiveness and safety of picosecond lasers for tattoo removal, Pubmed, Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov, and reference lists were searched for relevant trials. The primary outcome was >70 % clearance of tattoo pigment. Secondary outcomes were 90–100 % clearance of tattoo pigment, number of laser sessions required, and adverse effects. Eight trials were included, six with human participants (160 participants) and 2 with animal models. Seven of the eight trials explored the usage of either 755, 758, 795, 1064, or 1064/532-nm picosecond lasers for black and blue ink tattoos. In the human trials, 69–100 % of tattoos showed over 70 % clearance of pigment after 1–10 laser treatments. Reported side effects included pain, hyperpigmentation and hypopigmentation, blister formation and transient erythema, edema, and pinpoint bleeding. Included articles varied in type of laser investigated, mostly non-comparative studies and with a medium to high risk of bias. There is sparse evidence that picosecond lasers are more effective than their nanosecond counterparts for mainly black and blue ink tattoo removal, with minor side effects.
KW - 1064 nm
KW - 532 nm
KW - 755 nm
KW - 758 nm
KW - 795 nm
KW - Laser
KW - Laser treatment
KW - Nd-YAG
KW - Tattoo
KW - Tattoo removal
UR - http://www.scopus.com/inward/record.url?scp=84975126809&partnerID=8YFLogxK
U2 - 10.1007/s10103-016-2001-0
DO - 10.1007/s10103-016-2001-0
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27311768
AN - SCOPUS:84975126809
SN - 0268-8921
VL - 31
SP - 1397
EP - 1405
JO - Lasers in Medical Science
JF - Lasers in Medical Science
IS - 7
ER -